solithromycin + ceftriaxone + azithromycin
Phase 3Completed 0 watching 0 views this week📈 Rising
72
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Uncomplicated Urogenital Gonorrhea
Conditions
Uncomplicated Urogenital Gonorrhea
Trial Timeline
Aug 1, 2014 → Feb 22, 2017
NCT ID
NCT02210325About solithromycin + ceftriaxone + azithromycin
solithromycin + ceftriaxone + azithromycin is a phase 3 stage product being developed by Allergy Therapeutics for Uncomplicated Urogenital Gonorrhea. The current trial status is completed. This product is registered under clinical trial identifier NCT02210325. Target conditions include Uncomplicated Urogenital Gonorrhea.
Hype Score Breakdown
Clinical
27
Activity
18
Company
5
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02210325 | Phase 3 | Completed |
Competing Products
13 competing products in Uncomplicated Urogenital Gonorrhea
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| ZY19489 + Ferroquine (FQ) + Placebo | Zydus Lifesciences | Phase 1 | 33 |
| KLU156 + Coartem | Novartis | Phase 3 | 77 |
| Artemether-lumefantrine (COA566) | Novartis | Phase 2/3 | 65 |
| INE963 | Novartis | Phase 2 | 52 |
| KAE609 + SoC (Coartem) + KLU156 | Novartis | Phase 2 | 52 |
| KAF156 + Coartem + Lumefantrine Solid Dispersion Formulation | Novartis | Phase 2 | 52 |
| INE963 + KAE609 (Cipargamin) + SoC (Coartem) + KLU156 | Novartis | Phase 2 | 52 |
| KAF156 + LUM-SDF + Coartem | Novartis | Phase 2 | 52 |
| Co-artemether | Novartis | Approved | 85 |
| Broncho-munal® + Placebo | Sandoz Group | Phase 3 | 74 |
| Placebo of Phenazopyridine Hydrochloride Tables, USP 200 mg + Phenazopyridine Hydrochloride Tables, USP 200 mg | Amneal Pharmaceuticals | Phase 3 | 72 |
| Peramivir + Placebo | BioCryst Pharmaceuticals | Phase 2 | 47 |
| Sulopenem-Etzadroxil/Probenecid + Ciprofloxacin | Iterum Therapeutics | Phase 3 | 69 |
Other Products from Allergy Therapeutics
Atripla (r) + Efavirenz + Truvada + Rifampin/isoniazid/pyrazinamide/ethambutol FDC + Rifampin/isoniazid FDC + IsoniazidApproved
80
Doravirine 100 Mg + Integrase strand transfer inhibitors + Tenofovir alafenamide/emtricitabine + tenofovir disproxil fumarate/emtricitabineApproved
80
Sofosbuvir/Velpatasvir (SOF/VEL)Approved
80
Transdermal estradiol gel + Micronized Progesterone + Placebo for estradiol gel + Placebo for micronized progesteroneApproved
80
Efavirenz + Emtricitabine/Tenofovir disoproxil fumarateApproved
80